Trichomonas vaginalis is a parasitic protozoan that is the aetiological agent of trichomoniasis, the most common non-viral sexually transmitted disease worldwide. Currently, the compound of choice for the treatment of T. vaginalis infections is metronidazole, however, it has many side effects and an increase in metronidazole-resistant trichomoniasis has been observed. Medicinal plants could be a source of new antiprotozoal drugs with high activity, low toxicity and lower price. The present work was carried out to investigate the therapeutic potential of Nigella sativa alcoholic extract and oil, as well as Phaseolus vulgaris (kidney bean) lectin and their in vitro activity on the ultrastructure of T. vaginalis trophozoites in comparison to metronidazole, as detected by transmission electron microscope. Both N. sativa oil and P. vulgaris lectin showed high toxic effect as evidenced by severe cell damage with cytoplasmic and nuclear destruction, while the effect of N. sativa alcoholic extract was moderate. Therefore, these two extracts could offer an effective, cheaper and more safe alternative for metronidazole in treatment of trichomoniasis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996177PMC
http://dx.doi.org/10.1007/s12639-014-0564-xDOI Listing

Publication Analysis

Top Keywords

sativa alcoholic
12
alcoholic extract
12
nigella sativa
8
extract oil
8
oil well
8
well phaseolus
8
phaseolus vulgaris
8
vulgaris kidney
8
kidney bean
8
bean lectin
8

Similar Publications

Anxiety disorders are one of the top contributors to psychiatric burden worldwide. Recent years have seen a dramatic rise in the potential anxiolytic properties ascribed to cannabidiol (CBD), a non-intoxicating constituent of the Cannabis Sativa plant. This has led to several clinical trials underway to examine the therapeutic potential of CBD for anxiety disorders.

View Article and Find Full Text PDF

Cannabidiol (CBD) modulates the transcriptional profile of ethanol-exposed human dermal fibroblast cells.

J Appl Genet

December 2024

Faculty of Veterinary Medicine, Laboratory of Recombinant Proteins Production, University of Agriculture in Kraków, Rędzina 1C, 30-248, Kraków, Poland.

Cannabidiol (CBD) is abundant in the Cannabis sativa plant and exhibits complex immunomodulatory, anxiolytic, antioxidant, and antiepileptic properties. Several studies suggest that CBD could be used for different purposes in alcohol use disorder (AUD) and alcohol-related injuries to the brain and the liver. In this study, we focused on analyzing transcriptional alterations in human dermal fibroblasts (HDFs) cell line challenged simultaneously with ethanol and CBD as an ethanol-protective agent.

View Article and Find Full Text PDF
Article Synopsis
  • Cannabidiol (CBD) is a non-psychoactive compound from the cannabis plant that interacts with various receptors and has antioxidant properties.
  • Research suggests that CBD has significant effects on the gastrointestinal (GI) system, influencing intestinal permeability, the microbiome, and immune responses, making it promising for treating GI disorders like inflammatory bowel disease (IBD).
  • Future studies are essential to understand how CBD works in the gut and to conduct well-designed clinical trials to investigate its full therapeutic potential for both GI and non-GI related disorders.
View Article and Find Full Text PDF

Objective: Studies have shown the complications of chemotherapy on learning and memory. Empirical evidence suggests that (NS) has neuroprotective activities. Therefore, the aim of our study was to investigate the effects of NS on cisplatin-induced memory impairment.

View Article and Find Full Text PDF

A Novel Plant-Based Nutraceutical Combined with Exercise Can Revert Oxidative Status in Plasma and Liver in a Diet-Induced-Obesity Animal Model.

Antioxidants (Basel)

February 2024

Department of Physiology, Institute of Nutrition and Food Technology (INyTA), Biomedical Research Center (CIBM), Sport and Health University Research Institute (IMUDS), Universidad de Granada, 18016 Granada, Spain.

The prevalence of obesity increases alarmingly every year mostly due to external factors such as high-fat and high-refined sugar intake associated with a sedentary lifestyle. It triggers metabolic disorders such as insulin resistance, hyperlipemia, non-alcoholic fatty liver disease, chronic inflammation, oxidative stress, and gut microbiota dysbiosis. The aim of this study was to evaluate the beneficial effects of a combined intervention with caloric restriction, nutraceutical intake, and a mixed training protocol on oxidative stress, inflammation, and gut dysbiosis derived from the development of obesity in a C57BL6/J mouse experimental model of diet-induced obesity (4.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!